BIOOPTIMUS
LIVE

Serial Number

99677948

Owner

BIOPTIMUS

Attorney

Kaitlyn M. Garvin

Filing Date

Mar 2, 2026

Add to watchlist:

No watchlists yet
View on USPTO

BIOOPTIMUS Trademark

Serial Number: 99677948

BIOOPTIMUS is a trademark filed by BIOPTIMUS on March 2, 2026. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

BIOPTIMUS (6 trademarks)

14-16 Boulevard Poissonnière
Paris F-75009 , FR

Entity Type: 99

Trademark Details

Filing Date

March 2, 2026

Registration Date

Not Registered

Goods & Services

Downloadable computer software platforms for collecting, processing and analyzing biological and scientific data for research; Downloadable software for computational modeling and simulation of biological systems using multimodal data; Downloadable computer software using artificial intelligence (AI) for data processing, data generation and data analysis; Downloadable computer software using artificial intelligence (AI) for developing learning algorithms for data classification and decision support; Downloadable software for simulation environments to test AI algorithms; Downloadable computer software using artificial intelligence (AI) for conducting research in biology and life sciences; Downloadable computer software using artificial intelligence (AI) for biological model development and for analysis and prediction in oncology, chemistry, biology, cosmetics, agroengineering, agrochemistry, longevity medicine and personalized medicine; Downloadable software for deep learning, reinforcement learning, building neural networks, high performance computing, distributed computing, cloud computing, data analytics, mechanistic machine learning; Downloadable application programming interface (API) software for scientific modeling; Downloadable software development kits (SDK); Downloadable computer software for scientific modeling; Downloadable computer software for scientific modeling, namely, artificial intelligence (AI) model weights; Downloadable software using machine learning for tumor profiling and diagnostic modeling

Providing on-line non-downloadable software for collecting, processing, integrating and analyzing biological and scientific data for research; Research in the field of artificial intelligence (AI) technology; Consultancy in the field of artificial intelligence (AI) technology; Computer technology consultancy in the field of machine learning; Technology consultation in the field of data analytics; Research and development services in the field of engineering; Providing on-line non-downloadable software for computational modeling and simulation of biological systems using multimodal data; Providing on-line non-downloadable software for conducting research and tests in biology and life sciences using artificial intelligence (AI); Biotechnology research; Research and development services in the field of diagnostic preparations; Computer programming consultancy; Providing on-line non-downloadable software for biological model development and for data analysis and prediction in oncology, chemistry, biology, cosmetics, agroengineering, agrochemistry, longevity medicine and personalized medicine, using artificial intelligence (AI); Providing on-line non-downloadable software for deep learning, reinforcement learning, building neural networks, high performance computing, distributed computing, cloud computing, data analytics, mechanistic machine learning; Providing on-line non-downloadable software for modeling organic compounds and tumor profiling; Providing on-line non-downloadable software for creation of machine learning diagnostic models; Providing on-line non-downloadable software for analysis of genomic, proteomic and histology, pharmacokinetic, pharmacodynamics, clinical outcomes; Providing on-line non-downloadable software for scientific modeling, namely, software development kits (SDK) and application programming interface (API); Medical and scientific research, namely, conducting clinical trials for others

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 30, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 30, 2026 GNSL
SUSPENSION LETTER WRITTEN
Jun 30, 2026 CNSL
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 30, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Jun 30, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jun 30, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 30, 2026 CNEA
ASSIGNED TO EXAMINER
Jun 29, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 28, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 2, 2026 MAFR
NEW APPLICATION ENTERED
Mar 2, 2026 NWAP